Prevention Genetics Logo
Test Code 6064

Spinal Muscular Atrophy (SMA) via MLPA of SMN1 and SMN2

2 genes

2 - 3 weeks (6 - 11 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of spinal muscular atrophy
  • Individuals with newborn screening results consistent with SMN1-related spinal muscular atrophy
  • This test is NOT intended for carrier screening in the general population and will not provide residual risk
Method
Multiplex Ligation-Dependent Probe Amplification Assay
Specimen(s)

Blood, Buccal, Saliva

Order Options

OTHER OPTIONS
for pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.

    Prevention Genetics